J. Lopez-Campos Bodineau (Sevilla, Spain), S. Everaerts (Leuven, Belgium)
The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
J. Haughney (Glasgow, United Kingdom), A. Lee (Aberdeen, United Kingdom), M. Nath (Aberdeen, United Kingdom), H. Müllerová (Cambridge, United Kingdom), U. Holmgren (Gothenburg, Sweden), E. De Nigris (Cambridge, United Kingdom), B. Ding (Gothenburg, Sweden)
|     |
Prediction model of COPD acute exacerbation with big data by machine learning methods
C. Rhee (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), K. Jung (Anyang, Republic of Korea)
| |
Automated computed tomography lung densitometry in bronchiectasis patients
M. Yamada Sawamura (São Paulo (SP), Brazil), R. Abensur Athanazio (São Paulo (SP), Brazil), M. Nieves Teixeira Maiorano De Nucci (São Paulo (SP), Brazil), S. Zahi Rached (São Paulo (SP), Brazil), A. Cukier (São Paulo (SP), Brazil), R. Cavalho-Pinto (São Paulo (SP), Brazil), R. Stelmach (São Paulo (SP), Brazil), A. Nascimento Assunção Junior (São Paulo (SP), Brazil), M. Straus Takahashi (São Paulo (SP), Brazil), C. Higa Nomura (São Paulo (SP), Brazil)
| |
CT evaluations of erector spinae muscle, emphysema, and airway disease for predicting mortality in COPD
N. Tanabe (Kyoto, Japan), S. Sato (Kyoto, Japan), K. Tanimura (Kyoto, Japan), H. Shima (Kyoto, Japan), T. Oguma (Kyoto, Japan), A. Sato (Kyoto, Japan), S. Muro (Nara, Japan), T. Hirai (Kyoto, Japan)
| |
Validation of clinical clusters for long-term mortality in two European COPD cohorts
S. Gagatek (Uppsala, Sweden), S. Wijnant (Ghent, Belgium), B. Ställberg (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), G. Brusselle (Ghent, Belgium), X. Zhou (Uppsala, Sweden), M. Hasselgren (Örebro, Sweden), S. Montgomery (Örebro, Sweden), J. Sundh (Örebro, Sweden), J. Christer (Uppsala, Sweden), Ö. Emilsson (Uppsala, Sweden), L. Lahousse (Rotterdam, Netherlands), A. Malinovschi (Uppsala, Sweden)
| |
Difficult to manage COPD Exacerbations: Risk factors (DIMECO Study). Turkish Thoracic Society COPD Assembly.
A. Baha (Kyrenia, Cyprus), N. Kokturk (Ankara, Turkey), D. Yapar (Ankara, Turkey), S. Ozkan (Ankara, Turkey), E. Sen (Ankara, Turkey), F. Ciftci (Ankara, Turkey), B. Ozturk (Ankara, Turkey), S. Kodalak (Ankara, Turkey), G. Ulubay (Ankara, Turkey), I. Serifoglu (Hatay, Turkey), Y. Varol (Izmir, Turkey), A. Mertoglu (Izmir, Turkey), A. Cirak (Izmir, Turkey), O. Turan (Izmir, Turkey), N. Dursunoglu (Denizli, Turkey), N. Savurmus (Denizli, Turkey), A. Gurgun (Izmir, Turkey), F. Elmas (Izmir, Turkey), L. Coplu (Ankara, Turkey), U. Sertcelik (Ankara, Turkey), R. Yildiz (Istanbul, Turkey), I. Ozmen (Istanbul, Turkey), A. Alpaydin (Izmir, Turkey), M. Polatli (Aydin, Turkey), E. Karacay Yesiloglu (Ankara, Turkey), D. Celik (Ankara, Turkey)
| |
European expert consensus on assessment and management of hospitalised exacerbations of COPD (CICERO ERS CRC)
S. Ramakrishnan (Oxford, United Kingdom), W. Janssens (Leuven, Belgium), P. Burgel (Paris, France), M. Contoli (Ferrara, Italy), F. Franssen (Maastricht, Netherlands), N. Greening (Leicester, United Kingdom), T. Greulich (Marburg, Germany), I. Gyselinck (Leuven, Belgium), A. Huerta (Barcelona, Spain), J. Quint (London, United Kingdom), L. Van Fleteren (Göteborg, Sweden), H. Watz (Grosshandorf, Germany), M. Bafadhel (Oxford, United Kingdom)
| |